Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Corgentech Inc. is a privately held biotechnology company that is the leader in the discovery, development and commercialization of an exciting and powerful new class of therapeutics called transcription factor decoys or TF Decoys. The company’s proprietary technology platform is capable of delivering multiple new product candidates to treat diseases that affect large patient populations in a relatively short period of time. Currently, the company is focused in three therapeutic areas: cardiovascular disease, inflammatory disease and cancer. ( www.corgentech.com )
Corgentech Inc.
650 Gateway Boulevard
South San Francisco, California 94080
USA
Tel: (650) 624-9600
Fax: (650) 624-7540